Understanding how a specific brain pathway affects opioid behaviors
Official title: The role of the nigrothalamic pathway in opioid-driven behaviors
Funded at Colgate University · NIH-10730268 · Data updated 2026-11-12
This study is looking at how certain brain pathways affect how opioids help with pain and their potential for addiction, which could lead to better treatments for people dealing with chronic pain and opioid dependence.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colgate University NIH-funded |
| Lab location | 1 site (Hamilton, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $405,000 |
| NIH project number | 1R15DA057501-01A1 |
| Project ID | NIH-10730268 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from chronic pain or those at risk of opioid dependence.
✕Less likely to help
Patients who do not experience chronic pain or have no history of opioid use may not benefit from this research.
What this research studies
This research investigates the role of a brain pathway in how opioids influence pain relief and addictive behaviors. By using advanced techniques like optogenetics and chemogenetic manipulations in mice, the study aims to uncover the neural mechanisms that contribute to opioid addiction and pain management. The findings could lead to improved treatment strategies for chronic pain and opioid dependence, addressing a significant public health issue. Patients may benefit from a better understanding of how opioids work in the brain and potential new therapies.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer pain management strategies that reduce the risk of opioid addiction.
How similar studies have gone: While the specific pathway being studied is novel, previous research has shown success in understanding opioid mechanisms, indicating potential for impactful findings.
Where this research is happening
-
Colgate University
Hamilton, United States Active
Researchers
- Principal investigator: Galaj, Ewa Joanna — Colgate University
- Study coordinator: Galaj, Ewa Joanna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.